Cargando…

Volumetric Modulated Arc Therapy Improves Outcomes in Definitive Radiochemotherapy for Anal Cancer Whilst Reducing Acute Toxicities and Increasing Treatment Compliance

SIMPLE SUMMARY: Intensity-modulated radiotherapy (IMRT) is the standard of care in definitive chemoradiotherapy (CRT) for anal cancer. Only a limited number of studies have analyzed the clinical results with VMAT (volumetric modulated arc therapy, the advanced form of IMRT). We conducted a retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Possiel, Jacqueline, Ammon, Hanne Elisabeth, Guhlich, Manuel, Conradi, Lena-Christin, Ghadimi, Michael, Wolff, Hendrik Andreas, Schirmer, Markus Anton, Samel, Stephan, Mügge, Michael, Rieken, Stefan, Leu, Martin, Dröge, Leif Hendrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196749/ https://www.ncbi.nlm.nih.gov/pubmed/34064061 http://dx.doi.org/10.3390/cancers13112533

Ejemplares similares

Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

Postoperative Radiochemotherapy Using Modern Radiotherapy Techniques in Elderly Patients with Head and Neck Squamous Cell Carcinoma: The Challenge of Weighing Up Benefits and Harms of Treatment Modalities in Clinical Practice
por: Leu, Martin, et al.
Publicado: (2021)

Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
por: Dröge, Leif Hendrik, et al.
Publicado: (2015)

Evaluation of Prognosticators and Treatment-Related Side Effects in Patients Irradiated Postoperatively for Endometrial Cancer
por: Leu, Martin, et al.
Publicado: (2020)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

8-Oxoguanine DNA Glycosylase (OGG1) Cys326 Variant: Increased Risk for Worse Outcome of Patients with Locally Advanced Rectal Cancer after Multimodal Therapy
por: Leu, Martin, et al.
Publicado: (2021)

Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient- and treatment-related parameters
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

Identification of Risk Loci for Radiotoxicity in Prostate Cancer by Comprehensive Genotyping of TGFB1 and TGFBR1
por: Guhlich, Manuel, et al.
Publicado: (2021)

Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer
por: Sauter, Christina, et al.
Publicado: (2022)

Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome: A single-center retrospective analysis of 21 years’ practice
por: Guhlich, Manuel, et al.
Publicado: (2022)

A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT)
por: Stieler, Florian, et al.
Publicado: (2009)

Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes
por: Habermann, Felix-Nikolai Oschinka Jegor, et al.
Publicado: (2022)

Neoadjuvant volumetric modulated arc radiochemotherapy with a simultaneous integrated boost technique compared to standard chemoradiation for locally advanced rectal cancer
por: JANKARASHVILI, Natalia, et al.
Publicado: (2019)

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy
por: Tozzi, Angelo, et al.
Publicado: (2014)

Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer
por: Vieillot, Sabine, et al.
Publicado: (2010)

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
por: Sprenger, Thilo, et al.
Publicado: (2010)

The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer
por: Mai, Sabine Kathrin, et al.
Publicado: (2007)

Comparing Apparent Diffusion Coefficient and FNCLCC Grading to Improve Pretreatment Grading of Soft Tissue Sarcoma—A Translational Feasibility Study on Fusion Imaging
por: Hettler, Madelaine, et al.
Publicado: (2022)

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011)

Heterogeneity of KRAS Mutation Status in Rectal Cancer
por: Jo, Peter, et al.
Publicado: (2016)

Radiochemotherapy
Publicado: (1998)

Feasibility of Four-dimensional Adaptation of Volumetric Modulated Arc Therapy Based on Volumetric Modulated Arc Therapy-computed Tomography
por: Zhao, Xiaodong, et al.
Publicado: (2023)

Dual-gated volumetric modulated arc therapy
por: Fahimian, Benjamin, et al.
Publicado: (2014)

Dosimetric and delivery characterizations of full-arc and half-arc volumetric-modulated arc therapy for maxillary cancer
por: Miura, Hideharu, et al.
Publicado: (2012)

Treatment outcome after radiochemotherapy in anal cancer patients staged with (18)F-FDG-PET-CT
por: Braun, L.H., et al.
Publicado: (2020)

Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
por: Schiffmann, Leif, et al.
Publicado: (2013)

Evaluation of mixed energy partial arcs for volumetric modulated arc therapy for prostate cancer
por: Momin, Shadab, et al.
Publicado: (2019)

Continuing professional development whilst shielding
por: Newton, Lucy E. Homer, et al.
Publicado: (2021)

Evaluation of volumetric modulated arc therapy for postmastectomy treatment
por: Nichols, Geoffrey P, et al.
Publicado: (2014)

Prostate volumetric‐modulated arc therapy: dosimetry and radiobiological model variation between the single‐arc and double‐arc technique
por: Chow, James C.L., et al.
Publicado: (2013)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location
por: Adeberg, Sebastian, et al.
Publicado: (2018)

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
por: Martin, Daniel, et al.
Publicado: (2020)

Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases
por: Haas, Gwendolyn, et al.
Publicado: (2021)

Volumetric‐modulated arc therapy using multicriteria optimization for body and extremity sarcoma
por: Young, Michael R., et al.
Publicado: (2016)

Hunger Whilst “In Utero” Programming Adult Osteoporosis
por: Weisz, George M., et al.
Publicado: (2014)

Strongyloides—An uncommon cause of eosinophilia whilst on durvalumab
por: Quah, Gaik Tin, et al.
Publicado: (2022)

Automatic interactive optimization for volumetric modulated arc therapy planning
por: Tol, Jim P, et al.
Publicado: (2015)

Assessing the role of volumetric‐modulated arc therapy in hepatocellular carcinoma
por: Xi, Mian, et al.
Publicado: (2013)

Dosimetric Effect of Jaw Tracking in Volumetric-Modulated Arc Therapy
por: Thongsawad, Sangutid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ses4jt5jn7nh4hdhcfqrf3c2qp